Table 2.
Characteristic | Value | Percentage (%) |
---|---|---|
| ||
Age | ||
Median | 60 | -- |
Range | 35–77 | -- |
| ||
Performance status | ||
0 | 5 | 56 |
1 | 4 | 44 |
| ||
Tumor Location | ||
Middle third | 1 | 11 |
Lower third | 6 | 67 |
GE junction | 2 | 22 |
| ||
Histology | ||
Squamous cell carcinoma | 2 | 22 |
Adenocarcinoma | 7 | 78 |
| ||
Stage Grouping (Clinical) | ||
II | 3 | 33 |
III | 6 | 67 |
| ||
T Stage (Clinical) | ||
T2 | 2 | 22 |
T3 | 7 | 78 |
| ||
N Stage (Clinical) | ||
N0 | 2 | 22 |
N1 | 6 | 67 |
N2 | 0 | 0 |
N3 | 1 | 11 |
| ||
Grade | ||
G1 | 2 | 22 |
G2 | 2 | 22 |
G3 | 4 | 44 |
Unavailable | 1 | 11 |